Navigation Links
Malvern initiates European user group meetings for chemical imaging

WORCESTERSHIRE , England, 21 June 2007, Malvern Instruments has held the inaugural meeting in Europe for users of the company's near infrared chemical imaging (NIR-CI) systems. The one-day event, which took place on 13 June 2007 was hosted by AstraZeneca in Macclesfield, UK. Malvern customers from some of the world's major pharmaceutical companies joined Malvern's technical and scientific teams for a program that included oral and poster presentations on the application of NIR-CI, and the opportunity to exchange experiences and ideas.

During the first sessions, presentations from users included: 'Chemical imaging and quality by design'; 'Moving NIR chemical imaging from lab to process-based methodology'; 'Applications of NIR imaging in drug development'; and 'Content uniformity determination'. The final parts of the day were devoted to instrumentation and software, together with a session on morphological imaging.

Linda Kidder, Malvern's product manager for chemical imaging systems, felt that the day was extremely valuable. "This was our first chemical imaging user meeting in Europe and we were very pleased with the response from our customers," she said. "Attendees came from a number of different European countries and shared their experiences through oral or poster presentations. The pharmaceutical industry is currently the biggest user of Malvern's chemical imaging systems and it was good to hear more about the various applications for which they are being used." A similar meeting will be held for chemical imaging users in the United States later in the year.

Malvern's recently launched SyNIRgi system underlines the continuing migration of NIR-CI technology from its specialist roots into routine use as a highly desirable, quantitative analytical tool. The hallmarks of SyNIRgi are its rugged construction with no moving parts, modular software that enables the development of turnkey soluti ons, and expandability options for automation accessories. Since NIR chemical imaging provides robust, reliable and automated data collection that is coupled tightly with quantitative, statistical, objective, reproducible and automated data processing tools, it is highly suited for routine analytical measurements. SyNIRgi is designed with this in mind. <>


High resolution image attached or available from Trish Appleton,

Kapler Communications Ref: MAL/JOB/1229

About Malvern Instruments

Malvern Instruments is a global company that develops, manufactures and markets advanced analytical systems used in characterizing a wide variety of materials, from bulk powders to the latest nanomaterials and delicate macromolecules. Innovative technologies and powerful software produce systems that deliver industrially relevant data enabling customers to make the connection between micro (eg particle size) and macro (bulk) material properties (rheology) and chemical composition (chemical imaging). Malvern laboratory, on-line and in-line solutions are proven in sectors from cement to pharmaceuticals and support the understanding, improvement and optimization of many industrial processes.

Headquartered in Malvern, UK, the company has subsidiary organizations in all major European markets, North America, China, Korea and Japan, key partnerships in India, a global distributor network and a number of applications laboratories around the world. <>

For press information, please contact

Trish Appleton, Kapler Communications

Suite 2, Cressner House, 1 2 Huntingdon Street, St Neots, Cambs PE19 1BD UK

Tel: +44 (0) 1480 471117; Fax: +44 (0) 1480 471118

USA contact:

Marisa Fraser, Malvern Instruments Inc

10 Southville Road, Southborough, MA 01772, USA

Tel: +1 508 480 0200; Fax: +1 508 460 9692

Please send sales enquiries to:

Alison Vines, Malvern Instruments Ltd

Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ UK

Tel: +44 (0) 1684 892456; Fax: +44 (0) 1684 892789


Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
7. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
8. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
9. Inspire Announces Presentations at Two European Scientific Conferences
10. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
11. Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent at European Association for Palliative Care Congress
Post Your Comments:
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... meeting of shareholders held today, the Company,s shareholders voted ... the previously announced agreement and plan of merger (the ...
(Date:11/24/2015)... , Nov. 24, 2015  In the pharmaceutical ... in an effort to quickly uncover new insights, tactics ... --> --> However, organizations ... market research project and ensure that all rules and ... industry standards. Another major barrier to efficiently launching market ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... AL (PRWEB) , ... November 24, 2015 , ... American ... announced today the opening of a holiday pop-up clinic located in Metro Atlanta’s North ... needs in a new and different way. The location is scheduled to operate through ...
Breaking Medicine News(10 mins):